Thermal management where it really matters: your pharmaceutical facility

Pharmaceutical facilities are often among the most demanding environments to operate. These spaces are where biologics are manufactured, where life-saving medicines are developed and where the next generation of vaccines will be created. With global pharmaceutical R&D investment reaching approximately $190 billion in 2024, protecting product quality, meeting compliance requirements and supporting research has never been more important.

As pharmaceutical organizations expand production capacity, new manufacturing processes can create changing thermal demands. At the same time, facility leaders face pressure to reduce energy consumption, control costs and maintain tightly regulated environments. As a result, thermal management has become more than a facilities concern. It’s now a strategic business priority.

Thermal management is much more than temperature control

The scale of pharmaceutical innovation highlights the importance of efficient thermal management. On average, it can take 10-15 years of research, development, testing and regulatory review before a new therapy reaches approval. Keeping products safe and maintaining stable operational conditions throughout that process makes environmental control essential in pharmaceutical facilities.

As the product progresses to the manufacturing phase, production volumes often increase or vary over time, putting increased pressure on thermal infrastructure to support operational performance and long-term efficiency. This is particularly true in GMP-regulated manufacturing environments.

As a result, facility leaders are evaluating whether existing cooling systems can meet future operational needs without adding complexity, costs or continuity risk. This is driving greater interest in central plant technologies that can deliver precise and efficient performance across a wide range of operating conditions while helping organizations manage long-term ownership costs.

Reliable cooling at scale

As cooling requirements grow in parallel to decarbonization demands, pharmaceutical organizations are looking for technologies that can perform at scale while improving operational efficiency. With cooling plants sitting at the heart of this issue, modern centrifugal chillers have evolved considerably to meet these requirements.

The Johnson Controls YORK® YK centrifugal chiller is a prime example of this evolution. Designed for large-scale applications, it combines high-capacity cooling with ultra-low-GWP refrigerant and advanced operational capabilities. Technologies such as the OptiView control interface provide greater visibility into system performance and operating conditions. For pharmaceutical facilities, where production schedules and operating conditions can change over time, maintaining efficient performance across varying loads is becoming increasingly important. The YORK® YK is designed with these priorities in mind, helping balance operational continuity, efficiency and long-term infrastructure performance.

Creating the conditions for an efficient future

Dependable thermal performance is not determined by a single piece of equipment, but by how cooling infrastructure, controls, operational visibility and service expertise work together to support critical environments. That’s why leading facilities are moving beyond selecting equipment based solely on first cost and are instead evaluating reliability, serviceability and lifecycle performance.

At Boehringer Ingelheim's Campinas pharmaceutical manufacturing site in Brazil, Johnson Controls helped modernize HVAC operations through a more proactive and predictive service approach. By restoring system performance and improving visibility into asset health, the site achieved 98% HVAC availability, supporting the reliable operation of critical pharmaceutical environments where it really matters.

The future of thermal management in pharmaceutical facilities isn't simply greater cooling capacity. It's intelligent, integrated and adaptable thermal infrastructure capable of supporting changing production requirements without compromising quality or compliance.

At Johnson Controls, we're helping shape how modern pharmaceutical facilities think about thermal performance, moving the conversation beyond cooling capacity alone toward resilience, operational continuity, lifecycle performance and connected infrastructure.